{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:07:57Z","timestamp":1789189677769,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.pcad.2026.04.011","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:02:06Z","timestamp":1777590126000},"page":"67-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Lipoprotein(a), remnant cholesterol, and high-sensitivity C-reactive protein as complementary biomarkers for myocardial infarction risk assessment"],"prefix":"10.1016","volume":"96","author":[{"given":"Richard","family":"Kazibwe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Schaich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff A.","family":"Kingsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parag","family":"Chevli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Mirzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi","family":"Rikhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2026.04.011_bb0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/clinchem\/hvaa252","article-title":"Residual cardiovascular risk at low LDL: remnants, Lipoprotein(a), and inflammation","volume":"67","author":"Hoogeveen","year":"2021","journal-title":"Clin Chem"},{"key":"10.1016\/j.pcad.2026.04.011_bb0010","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa2405182","article-title":"Inflammation, cholesterol, lipoprotein(a), and 30-year cardiovascular outcomes in women","volume":"391","author":"Ridker","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2026.04.011_bb0015","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1093\/eurheartj\/ehaf281","article-title":"Low-density lipoprotein cholesterol, lipoprotein(a) and high-sensitivity C-reactive protein are independent predictors of cardiovascular events","volume":"46","author":"Markus","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.04.011_bb0020","doi-asserted-by":"crossref","first-page":"612","DOI":"10.7326\/0003-4819-149-9-200811040-00004","article-title":"Composite outcomes in cardiovascular research: a survey of randomized trials","volume":"149","author":"Lim","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2026.04.011_bb0025","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","article-title":"Mechanisms of plaque formation and rupture","volume":"114","author":"Bentzon","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2026.04.011_bb0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pcad.2026.04.011_bb0035","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jamacardio.2021.3508","article-title":"Association between cumulative low-density lipoprotein cholesterol exposure during young adulthood and middle age and risk of cardiovascular events","volume":"6","author":"Zhang","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.pcad.2026.04.011_bb0040","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1161\/CIRCULATIONAHA.122.061010","article-title":"Low-density lipoprotein cholesterol is predominantly associated with atherosclerotic cardiovascular disease events in patients with evidence of coronary atherosclerosis: the Western Denmark heart registry","volume":"147","author":"Mortensen","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2026.04.011_bb0045","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jamacardio.2022.0987","article-title":"Lipoprotein(a) and its significance in cardiovascular disease: a review","volume":"7","author":"Duarte Lau","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.pcad.2026.04.011_bb0050","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1161\/ATVBAHA.123.319297","article-title":"Independent causal effect of remnant cholesterol on atherosclerotic cardiovascular outcomes: a mendelian randomization study","volume":"43","author":"Navarese","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pcad.2026.04.011_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5551\/jat.RV22044","article-title":"High-sensitivity C-reactive protein and residual inflammatory risk in coronary artery disease: the pathophysiology, prognosis, and emerging therapies","volume":"33","author":"Katamine","year":"2026","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.pcad.2026.04.011_bb0060","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the Management of Blood Cholesterol: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.04.011_bb0065","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/HCO.0000000000001140","article-title":"Predictive utility of remnant cholesterol in atherosclerotic cardiovascular disease","volume":"39","author":"Proctor","year":"2024","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.pcad.2026.04.011_bb0070","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.pharmthera.2013.11.008","article-title":"Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment","volume":"141","author":"Varbo","year":"2014","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pcad.2026.04.011_bb0075","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(24)01308-4","article-title":"Lipoprotein (a) and cardiovascular disease","volume":"404","author":"Nordestgaard","year":"2024","journal-title":"The Lancet"},{"key":"10.1016\/j.pcad.2026.04.011_bb0080","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11883-025-01288-w","article-title":"Remnant cholesterol: should it be a target for prevention of ASCVD?","volume":"27","author":"Doi","year":"2025","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.pcad.2026.04.011_bb0085","doi-asserted-by":"crossref","first-page":"e70020","DOI":"10.1111\/eci.70020","article-title":"Inflammation in atherosclerotic cardiovascular disease: from diagnosis to treatment","volume":"55","author":"Arnold","year":"2025","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.pcad.2026.04.011_bb0090","doi-asserted-by":"crossref","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.pcad.2026.04.011_bb0095","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/ije\/dym276","article-title":"The UK biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine","volume":"37","author":"Elliott","year":"2008","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.pcad.2026.04.011_bb0100","series-title":"Lipoprotein (a) Assay","author":"Reagent","year":"2024"},{"key":"10.1016\/j.pcad.2026.04.011_bb0105","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1093\/clinchem\/46.12.1956","article-title":"Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein (a)","volume":"46","author":"Marcovina","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/j.pcad.2026.04.011_bb0110","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/eurheartj\/ehac822","article-title":"Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality","volume":"44","author":"Wadstr\u00f6m","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.04.011_bb0115","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1093\/eurheartj\/ehab432","article-title":"Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study","volume":"42","author":"Quispe","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.04.011_bb0120","doi-asserted-by":"crossref","first-page":"e203959","DOI":"10.1001\/jamanetworkopen.2020.3959","article-title":"Association of rare pathogenic DNA variants for familial hypercholesterolemia, hereditary breast and ovarian cancer syndrome, and lynch syndrome with disease risk in adults according to family history","volume":"3","author":"Patel","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.pcad.2026.04.011_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2021.111350","article-title":"Time spent outdoors and risk of myocardial infarction and stroke in middle and old aged adults: results from the UK biobank prospective cohort","volume":"199","author":"Miguet","year":"2021","journal-title":"Environ Res"},{"key":"10.1016\/j.pcad.2026.04.011_bb0130","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1017\/S0047279400020341","article-title":"Deprivation","volume":"16","author":"Townsend","year":"1987","journal-title":"J Soc Policy"},{"key":"10.1016\/j.pcad.2026.04.011_bb0135","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2026.04.011_bb0140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1373\/clinchem.2017.279463","article-title":"Remnant cholesterol and myocardial infarction in Normal weight, overweight, and obese individuals from the Copenhagen general population study","volume":"64","author":"Varbo","year":"2018","journal-title":"Clin Chem"},{"key":"10.1016\/j.pcad.2026.04.011_bb0145","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1373\/clinchem.2014.234146","article-title":"Extreme nonfasting remnant cholesterol vs extreme LDL cholesterol as contributors to cardiovascular disease and all-cause mortality in 90000 individuals from the general population","volume":"61","author":"Varbo","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.pcad.2026.04.011_bb0150","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jacc.2021.07.016","article-title":"High-sensitivity C-reactive protein modifies the cardiovascular risk of lipoprotein(a): multi-ethnic study of atherosclerosis","volume":"78","author":"Zhang","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.04.011_bb0155","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1016\/j.jacl.2024.03.001","article-title":"A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice","volume":"18","author":"Koschinsky","year":"2024","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.pcad.2026.04.011_bb0160","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"The Lancet"},{"key":"10.1016\/j.pcad.2026.04.011_bb0165","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/jamacardio.2020.0013","article-title":"A new equation for calculation of low-density lipoprotein cholesterol in patients with Normolipidemia and\/or hypertriglyceridemia","volume":"5","author":"Sampson","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.pcad.2026.04.011_bb0170","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","article-title":"Clinical application of C-reactive protein for cardiovascular disease detection and prevention","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2026.04.011_bb0175","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamacardio.2019.3780","article-title":"Apolipoprotein B particles and cardiovascular disease: a narrative review","volume":"4","author":"Sniderman","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.pcad.2026.04.011_bb0180","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","article-title":"Remnant cholesterol as a causal risk factor for ischemic heart disease","volume":"61","author":"Varbo","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.04.011_bb0185","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1373\/clinchem.2011.165712","article-title":"Biomarkers and cardiovascular risk assessment for primary prevention: an update","volume":"58","author":"Gilstrap","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.pcad.2026.04.011_bb0190","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.jacc.2023.07.018","article-title":"Performance of the ACC\/AHA pooled cohort cardiovascular risk equations in clinical practice","volume":"82","author":"Medina-Inojosa","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.04.011_bb0195","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1038\/s41591-025-03789-2","article-title":"Performance of the American Heart Association\u2019s PREVENT risk score for cardiovascular risk prediction in a multiethnic population","volume":"31","author":"Mathew","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.pcad.2026.04.011_bb0200","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/jamacardio.2022.2638","article-title":"Coronary artery calcium test for heart disease risk assessment","volume":"7","author":"Greenland","year":"2022","journal-title":"JAMA Cardiol"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062026000411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062026000411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:40:01Z","timestamp":1789188001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062026000411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":40,"alternative-id":["S0033062026000411"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2026.04.011","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein(a), remnant cholesterol, and high-sensitivity C-reactive protein as complementary biomarkers for myocardial infarction risk assessment","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2026.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}